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Abstract
Introduction:  Patients  with  squamous  cell  carcinoma  of  the  oral  cavity  present  deﬁcits  in  their
cellular immunity  that  contribute  to  neoplastic  growth.  Thus,  the  inﬂammatory  activity,  such
as the  immunological  response  to  the  tumor,  can  be  used  as  a  prognostic  factor.
Objectives:  To  evaluate  the  correlation  between  peritumoral  inﬂammation  and  clinical  char-
acteristics of  the  patients,  survival,  and  the  disease-free  interval.
Methods:  The  study  sample  consisted  of  a  retrospective  hospital-based  cohort  of  patients
undergoing  surgery  for  resection  of  oral  cavity  tumor.  The  inﬂammatory  inﬁltrate  on  the  slides
was evaluated  semi-quantitatively,  and  were  divided  into  minor  and  major  inﬂammatory  pro-
cesses.
Results: This  study  included  57  tumor  samples,  with  inﬁltration  of  lymphocytes,  plasma  cells,
and histiocytes.  The  log-rank  test  showed  no  signiﬁcance  for  the  survival  curves  and  recurrence
of the  ‘‘minor  inﬂammatory’’  and  ‘‘major  inﬂammatory’’  processes,  with  p  =  0.14  and  p  =  0.24,
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respectively.  A  direct  association  between  age  and  inﬂammation  (p  =  0.04)  was  observed,  as
well as  an  indirect  association  between  the  degree  of  tumor  differentiation  and  inﬂammation
(p =  0.01).
Conclusion:  Although  associated  with  histological  differentiation,  the  peritumoral  inﬂammatory
process  cannot  be  considered  a  prognostic  factor  in  squamous  cell  carcinoma  of  the  oral  cavity,
as it  is  not  related  to  survival  and  disease-free  interval.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Inﬁltrado  peritumoral  no  prognóstico  do  carcinoma  epidermoide  de  cavidade  oral
Resumo
Introduc¸ão:  Pacientes  com  carcinoma  epidermoide  de  cavidade  oral  mostram  déﬁcits  em  sua
imunidade  celular,  que  contribuem  para  o  crescimento  neoplásico.  Assim,  a  atividade  inﬂa-
matória, como  resposta  imunológica  ao  tumor,  pode  servir  como  fator  prognóstico.
Objetivos:  Avaliar  a  correlac¸ão  entre  o  processo  inﬂamatório  peritumoral  com  as  características
clínicas dos  pacientes,  com  a  sobrevida  e  com  o  tempo  livre  de  doenc¸a.
Método:  A  amostra  deste  estudo  foi  composta  por  uma  coorte  retrospectiva  de  base  hospitalar
com pacientes  submetidos  à  cirurgia  para  remoc¸ão  de  carcinoma  epidermoide  de  cavidade
oral. O  inﬁltrado  inﬂamatório  presente  nas  lâminas  foi  avaliado  semi  quantitativamente,  sendo
dividido  em  processo  inﬂamatório:  menor  e  maior.
Resultados:  Analisaram-se  57  amostras  tumorais,  com  inﬁltrado  de  linfócitos,  plasmócitos  e
histiócitos.  O  teste  log-rank  não  mostrou  signiﬁcância  para  as  curvas  de  sobrevida  e  de  recidiva
dos processos  ‘‘inﬂamatório  menor’’  e  ‘‘inﬂamatório  maior’’,  p  =  0,14  e  p  =  0,24,  respectiva-
mente. Observou-se  associac¸ão  direta  da  idade  com  o  processo  inﬂamatório  (p  =  0,04),  e  relac¸ão
indireta entre  o  grau  de  diferenciac¸ão  tumoral  e  o  processo  inﬂamatório  (p  =  0,01).
Conclusão:  O  processo  inﬂamatório  peritumoral,  embora  relacionado  com  a  diferenciac¸ão  his-
tológica,  não  pode  ser  considerado  fator  prognóstico  de  carcinoma  epidermoide  de  cavidade
oral, pois  não  se  relaciona  com  sobrevida  e  tempo  livre  da  doenc¸a.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Despite  treatment  advances  over  the  last  20  years,  squa-
mous  cell  carcinoma  of  the  oral  cavity  (SCCOC)  continues  to
have  survival  rates  at  ﬁve  years  of  45--50%,1--3 mainly  due
to  its  heterogeneous  behavior.4 This  fact  has  led  to  several
studies  aiming  to  detect  biological  and  molecular  charac-
teristics  that  may  indicate  prognosis  and  treatment  of  these
tumors;  most  of  them  relate  to  histopathological  staging
of  the  surgical  specimen  and  do  not  have  direct  impact  on
clinical  practice.5 Currently,  it  is  also  known  that  the  pres-
ence  of  neck  metastasis  and  surgical  margin  involvement  are
prognostic  factors  for  SCCOC.6,7
Innate  immunity  is  the  ﬁrst  reaction  of  the  host  to
an  offending  agent.  Adaptive  immunity  is  a  delayed  type
of  immunity  that  leaves  immunological  memory,  with  the
participation  of  B  lymphocytes  (humoral  immunity)  and
cytotoxic  T  lymphocyte  (cellular  immunity).  According  to
Abbas  et  al.8 the  main  anti-tumor  defense  mechanism  is
the  death  of  neoplastic  cells  by  CD8+  T  or  cytotoxic  T
lymphocytes.  However,  individuals  with  SCCOC  have  cel-
lular  immunity  deﬁcits,  including  alterations  in  monocyte
chemotaxis  and  defects  in  the  interaction  between  the
monocytes  that  have  antigens  and  lymphocytes.  These
T
b
oefects  contribute  to  neoplastic  growth.  According  to
hiteside9 the  same  mechanisms  used  for  immunological
scape  in  human  malignancies  may  explain  discrepancies
etween  failures  and  successes  in  immunotherapy.
Inﬂammatory  activity,  such  as  immunological  response
o  the  tumor,  could  be  used  as  a  prognostic  factor,  since
he  lower  the  inﬂammatory  inﬁltrate,  the  greater  the
isk  of  regional  or  distant  metastasis.10--12 However,  Vieira
t  al.7 observed  a  correlation  between  a  higher  degree  of
alignancy  and  higher  inﬂammatory  intensity,  suggesting  a
ositive  association  between  the  intensity  of  the  inﬂam-
atory  response  and  the  degree  of  tumor  differentiation,
ithout  necessarily  inﬂuencing  patient  prognosis.
Therefore,  this  study  aimed  to  evaluate  the  correlation
etween  the  peritumoral  inﬂammatory  process  and  clinical
haracteristics  of  patients  with  SCCOC,  as  well  as  survival
nd  disease-free  interval.
ethodshe  study  sample  consisted  of  a retrospective  hospital-
ased  cohort  of  patients  undergoing  surgery  from  March
f  2003  to  June  of  2010  for  resection  of  SCCOC,  of  which
4 Affonso  VR  et  al.
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urgical  specimens  were  part.  Data  related  to  the  indepen-
ent  variables  that  could  be  associated  to  the  survival  of
ancer  patients,  such  as  sociodemographic  variables  (gen-
er,  age,  smoking  status,  and  alcohol  consumption),  clinical
ariables  (primary  subsite),  clinical  staging  (TNM,  clinical
tage),  and  histological  staging  (differentiation,  angiolym-
hatic  invasion,  and  perineural  invasion)  were  obtained
hrough  medical  ﬁle  review.
Excluded  were  patients  who  did  not  have  tumor  tissue
amples  stored,  as  well  as  those  with  a  surgical  margin  com-
romised  by  the  tumor  at  the  histopathological  analysis  of
urgical  specimens,  patients  lost  to  post-surgical  follow-up,
nd  those  who  died  from  causes  unrelated  to  the  disease.
ll  studied  subjects,  at  the  time  of  the  surgery,  signed  the
nformed  consent  form  approved  by  the  Research  Ethics
ommittee  (REC  No.  9371/2003).
istological  analysis
istopathological  assessment  of  the  cases  was  conducted  at
he  Department  of  Pathology,  after  the  parafﬁn  blocks  were
emoved  from  the  Head  and  Neck  Surgery  Surgical  Specimen
ank  (CEP  No.  9371/2003).  These  blocks  were  processed  to
btain  four-micrometer  sections  and  routinely  stained  with
ematoxylin  and  eosin  (HE)  for  histological  analysis.
The  peritumoral  inﬂammatory  inﬁltrate  was  character-
zed  by  the  inﬂux  of  mononuclear  cells  from  the  chronic
nﬂammatory  process  (lymphocytes,  plasmocytes,  and  his-
iocytes)  into  the  connective  tissue  that  permeates  the
nvading  neoplastic  cells  that  have  broken  the  basal  mem-
rane  of  the  squamous  epithelial  oral  mucosa.  This  inﬁltrate
as  stained  with  hematoxylin-eosin  and  the  4  micron-thick
umor  histological  sections  were  assessed  by  two  experi-
nced  examiners  using  the  semiquantitative  method  by  light
icroscopy  with  objective  lens,  with  a  40×  magniﬁcation.
he  inﬂammatory  inﬁltrate  was  quantiﬁed  as:
-  Grade  0:  when  no  or  only  rare  mononuclear  inﬂamma-
tory  cells  (lymphocytes,  plasmocytes,  and/or  histiocytes)
were  identiﬁed  in  the  interface  between  the  invasive
tumor  and  chorion;
-  Grade  1  (mild):  when  less  than  50%  of  the  interface
between  the  invasive  tumor  and  chorion  was  inﬁltrated
by  mononuclear  inﬂammatory  cells;
- Grade  2  (moderate):  when  the  inﬂammatory  inﬁltrate  was
≥50%  and  ≤75%  in  the  tumor-chorion  interface;
-  Grade  3  (intense):  when  the  inﬂammatory  response  was
present  in  >75%  of  the  tumor-chorion  interface.
tatistical  analysis
or  the  statistical  analysis,  patients  with  inﬂammatory  pro-
ess  grade  zero  and  one  (0  and  1)  were  grouped  as  minor
nﬂammatory  process  and  those  classiﬁed  as  grades  2  and  3,
s  major  inﬂammatory  process.  Two  response  variables  were
onsidered  separately:  death  and  recurrence.  For  each  one,
he  association  with  the  inﬂammatory  process  (explanatory
ariable)  was  assessed.
Survival  curves  for  each  variable  were  estimated  by  the
aplan--Meier  method,  which  were  compared  using  the  log-
ank  test.  Cox  regression  (proportional  hazards  model)  was
o
i
pigure  1  Kaplan--Meier  survival  estimates,  per  inﬂammatory
rocess.
sed  to  evaluate  the  effect  of  the  inﬂammatory  process  on
esponse  (death  or  recurrence),  considering  the  adjustment
or  each  of  the  other  variables.13
The  association  of  the  inﬂammatory  process  with  the
ther  sociodemographic  aspects,  clinical  aspects,  clinical
taging,  and  histological  staging  variables  were  evaluated
y  Fisher’s  exact  test.
esults
 total  of  57  tumor  samples  were  analyzed,  in  which  the  per-
tumoral  inﬂammatory  inﬁltrate  consisted  of  lymphocytes,
lasmocytes,  and/or  histiocytes.
Fig.  1  shows  that  the  probability  of  survival  in  over  12
onths  was  0.75  (95%  CI:  0.56--0.87)  for  individuals  with
inor  inﬂammatory  process  (Grades  0  and  1)  and  0.88  (95%
I  >  0.66--0.96)  for  subjects  with  major  inﬂammatory  process
Grades  2  and  3).  The  log-rank  test  used  to  compare  survival
urves  of  both  processes  showed  no  signiﬁcance  (p  =  0.14).
The  Cox  proportional  hazards  model  was  used  to  assess
ifferences  between  inﬂammatory  processes  when  adjusted
or  variables  that  were  signiﬁcant  in  the  log-rank  test.  When
djusted  for  smoking,  there  was  a  difference  in  inﬂamma-
ory  response  (p  =  0.05);  for  the  other  variables,  the  results
ere  not  signiﬁcant.
Tumor  recurrence  is  shown  in  Fig.  2.  The  log-rank  test
sed  to  compare  the  recurrence  curves  for  both  processes
as  not  signiﬁcant  (p  =  0.24).
Positive  signiﬁcance  for  recurrence  was  observed  when
onsidering  age  (p  =  0.04),  smoking  (p  <  0.01),  alcoholism
p  <  0.01),  and  degree  of  tumor  differentiation  (p  =  0.02).
he  other  variables  were  not  signiﬁcant.
The  Cox  proportional  hazards  model  was  used  to  assess
he  differences  between  inﬂammatory  processes  when
djusted  for  variables  that  were  signiﬁcant  in  the  log-rank
est.  When  adjusting  for  smoking,  a  difference  was  observed
etween  the  inﬂammatory  processes  (p  =  0.05).The  association  of  the  inﬂammatory  process  with  the
ther  variables  can  be  observed  in  Tables  1  and  2.  There
s  a  direct  association  between  age  and  the  inﬂammatory
rocess  (p  =  0.04),  as  major  inﬂammatory  processes  were
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Table  1  Frequency  distribution  of  the  inﬂammatory  process  in  relation  to  sociodemographic  variables  and  Fisher’s  exact  test
p-value.
Variable  p  Inﬂammatory  process  Total
n  Major  (%)  n  Minor  (%)
Age  0.04
>50 years  7  38.9  11  61.1  18
51--59 years  10  52.6  9  47.4  19
>60 years  15  79  4  21  14
Gender 0.18
Male  28  62.2  17  37.8  45
Female 4  36.4 7  63.6  11
Smoker 0.74
Yes 26  59.1  18  40.9  44
No 6  50  6  50  12
Alcohol consumption  0.57
Yes 22  61.1  14  38.9  36
50
p
t
nNo 10  
associated  with  older  ages  and  minor  inﬂammatory  pro-
cesses  with  younger  ages  (Table  1).Discussion
According  to  Roithmaier  et  al.14 the  immune  system  has  an
important  role  in  the  development  of  malignancies,  since
e
c
c
a
Table  2  Frequency  distribution  of  the  inﬂammatory  process  in
p-value.
Variable  p  
n  
Subsite  0.07
Floor  11  
Tongue 11  
Other 10  
TNM 0.09
T1  1  
T2 11  
T3 10  
T4 10  
Clinical staging  0.18
I 1  
II 7  
III 9  
IV 15  
Angiolymphatic  invasion  0.38
Yes  4  
No 28  
Neural invasion  1.00
Yes  9  
No 23  
Differentiation  0.01
Little  9  
Moderate 18  
High 5   10  50  20
atients  undergoing  immunosuppression  to  receive  organ
ransplants  were  21  times  more  likely  to  have  head  and  neck
eoplasms  than  the  overall  population.  Moreover,  Galon
15t  al. veriﬁed  that  the  immune  system  also  inﬂuences  can-
er  recurrence,  as  in  colon  cancer,  and  the  presence  of  T
ells  in  the  resected  tumor  predicts  tumor  evolution  more
ccurately  than  staging.  However,  the  role  of  the  immune
 relation  to  age  and  differentiation  and  Fisher’s  exact  test
Inﬂammatory  process  Total
Major  (%)  n  Minor  (%)
73.3  4  26.7  15
40.7 16  59.3  27
71.4 4  28.6  14
25  3  75  4
45.8  13  54.2  24
62.5  6  37.5  16
83.3  2  16.7  12
25  3  75  4
46.7  8  53.3  15
52.9  8  47.1  17
75  5  25  20
80  1  20  5
54.9  23  45.1  51
60  6  40  15
56.1  18  43.9  41
90  1  10  10
62.1  11  37.9  29
29.4  12  70.6  17
420  
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Rigure  2  Kaplan--Meier  estimates  of  recurrence  per  inﬂam-
atory  process.
ystem  in  cancer  progression  is  not  clear.  The  immune
urveillance  concept  states  that  the  system  should  recognize
nd  destroy  the  transformed  cell  clones  before  they  gener-
te  tumors.  However,  the  importance  of  such  surveillance
as  been  met  with  reservation,  since  they  do  not  appear
o  react  to  many  neoplasms.8 Conti-Freitas  et  al.16 when
nalyzing  cell  cultures  in  17  patients  with  laryngeal  cancer,
oncluded  that  there  was  a  deﬁciency  of  the  immunological
ystem  (decreased  induced  lymphoproliferation  in  stimu-
ated  cultures  and  deﬁciencies  in  the  production  of  IFN-y
nd  TNF- in  unstimulated  cultures)  that  tends  to  normalize
fter  tumor  resection  (laryngectomy)  or  BCG  use.
According  to  Whiteside9 there  are  several  possible  mech-
nisms  for  tumors  to  escape  immunologic  suppression
ncluding:  the  expression  of  poorly  immunogenic  antigens,
efects  in  antigen  processing  pathways,  inadequate  inter-
ctions,  and  production  of  immunosuppressive  factors  by
nﬂammatory  cells  adjacent  to  the  neoplasm.  We  believe
hat  is  was  what  happened  in  our  study,  since  no  statisti-
ally  signiﬁcant  differences  were  observed  comparing  the
rognostic  factors  survival  and  disease-free  interval,  with
he  presence  of  minor  and  the  major  inﬂammatory  pro-
esses.  This  result  may  be  due  to  sample  size  (57  tumors),  as
anzano  et  al.11 with  a  sample  of  46  patients  with  SCCOC,
lso  found  no  signiﬁcant  difference  between  the  intensities
f  peritumoral  inﬂammatory  inﬁltrate  and  survival  curves,
lthough  they  observed  that  the  more  frequent  the  presence
f  neck  metastasis,  the  lower  the  intensity  of  the  inﬁltrate.
In  this  study,  we  observed  a  statistically  signiﬁcant  dif-
erence  between  the  degree  of  tumor  differentiation  and
eritumoral  inﬂammatory  inﬁltrate;  the  lower  the  tumor
ifferentiation  (more  aggressive),  the  greater  the  inﬂam-
atory  process.
In a  similar  study,  Vieira  et  al.7 concluded  that  the  cellu-
ar  immune  response  is  a  major  defense  mechanism  of  the
ral  mucosa,  as  they  observed  the  expression  of  a  greater
umber  of  T  lymphocytes  in  undifferentiated  squamous  cell
arcinoma.  Moreover,  Manzano  et  al.11 showed  a  strong  ten-
ency  toward  a  worse  prognosis  among  tumors  with  poorly
ifferentiated  cells  and  less  inﬂammatory  inﬁltrate.
The  results  of  the  present  study  show  that,  as  tumor
tage  increases,  such  as  in  growth  (TNM  classiﬁcation),
here  is  a  trend  toward  increased  peritumoral  inﬂammatoryAffonso  VR  et  al.
nﬁltrate,  but  without  statistical  differences,  which  means
hat  the  inﬂammatory  inﬁltrate  tends  to  increase  along  with
he  tumor  mass  growth.  This  observation  leads  to  the  conclu-
ion,  as  Chaves  et  al.17 that  the  imbalance  in  the  immune
ystem  does  not  necessarily  correlate  with  the  number  of
efense  cells  that  are  present,  but  often  results  from  fail-
re  in  the  function,  regulation,  or  migration,  of  a  population
f  immune  cells  to  the  tumor  site.  Similarly,  Abreu  et  al.18
bserved  an  inverse  association  between  advanced  tumors
nd  degree  of  differentiation,  and  Costa  et  al.19 demon-
trated  worse  prognosis  in  advanced  tumors,  considering
etastasis  as  the  main  prognostic  indicator.
It  has  been  mentioned  that  the  intensity  of  the  inﬂam-
atory  inﬁltrate  ranges  from  mild  to  severe  in  tumors;
he  highest  density  of  inﬂammatory  cells  is  associated  with
ower  rates  of  recurrence  and,  when  lymphocytes  pene-
rate  the  tumor,  prognosis  is  more  favorable.15 However,  this
tudy  only  showed  that  older  patients  had  a  higher  incidence
f  inﬂammatory  process,  which  was  statistically  signiﬁcant;
owever,  this  increased  cell  density  did  not  translate  into
ncreased  survival.  It  is  believed  that  all  tested  cell  lines
re  present,  but  only  T  helper  lymphocytes  are  associated
ith  the  degree  of  tumor  malignancy  and  not  to  the  amount
f  inﬂammatory  cells.  Conversely,  Chaves  et  al.17 when
tudying  30  cases  of  SCCOC,  found  no  statistical  correlation
etween  inﬂammatory  inﬁltrate  and  age.
It  was  also  possible  to  verify  that  survival  and  recurrence
howed  an  association  with  smoking,  alcohol  consumption
nd  degree  of  tumor  differentiation,  similar  to  that  obtained
y  Montoro  et  al.6 who  observed  a statistical  signiﬁcance
etween  survival  and  the  following  variables:  age,  gender,
moking  and  alcohol  consumption,  while  Almeida  et  al.20
howed  an  association  between  smoking  and  alcohol  con-
umption  with  prognosis,  in  contrast  to  Oliveira  et  al.21 who
ound  no  inﬂuence  of  smoking  on  recurrences  and  metas-
ases.
Further  studies  must  be  conducted  with  a  larger  sample
ize  to  verify  the  real  inﬂuence  of  the  inﬂammatory  process
s  a  prognostic  factor  and  other  possible  interactions  with
ral  cancer.
onclusion
he  peritumoral  inﬂammatory  process,  although  associated
ith  the  degree  of  histological  differentiation,  cannot  be
onsidered  a  prognostic  factor  for  SCCOC,  as  it  is  not  associ-
ted  with  survival  and  disease-free  interval.  Additionally,
here  was  a  direct  association  between  the  peritumoral
nﬂammatory  process  and  factors  such  as  age,  smoking,  and
lcohol  consumption.
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